| New developments in lentiviral vector design, production and purification MM Segura, M Mangion, B Gaillet, A Garnier Expert opinion on biological therapy 13 (7), 987-1011, 2013 | 180 | 2013 |
| Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells A Garnier, J Côté, I Nadeau, A Kamen, B Massie Cell Culture Engineering IV: Improvements of Human Health, 145-155, 1995 | 175 | 1995 |
| Production of lentiviral vectors by large‐scale transient transfection of suspension cultures and affinity chromatography purification MM Segura, A Garnier, Y Durocher, H Coelho, A Kamen Biotechnology and bioengineering 98 (4), 789-799, 2007 | 174 | 2007 |
| Serum‐free production of recombinant proteins and adenoviral vectors by 293SF‐3F6 cells J Côté, A Garnier, B Massie, A Kamen Biotechnology and bioengineering 59 (5), 567-575, 1998 | 170 | 1998 |
| Downstream processing of oncoretroviral and lentiviral gene therapy vectors M De las Mercedes Segura, A Kamen, A Garnier Biotechnology Advances 24 (3), 321-337, 2006 | 122 | 2006 |
| A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography M de las Mercedes Segura, A Kamen, P Trudel, A Garnier Biotechnology and bioengineering 90 (4), 391-404, 2005 | 108 | 2005 |
| Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design V Cortin, A Garnier, N Pineault, R Lemieux, L Boyer, C Proulx Experimental hematology 33 (10), 1182-1191, 2005 | 107 | 2005 |
| Overview of current scalable methods for purification of viral vectors MM Segura, AA Kamen, A Garnier Viral Vectors for Gene Therapy: Methods and Protocols, 89-116, 2011 | 95 | 2011 |
| Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations MM Segura, A Garnier, MR Di Falco, G Whissell, A Meneses-Acosta, ... Journal of virology 82 (3), 1107-1117, 2008 | 91 | 2008 |
| Improvement of recombinant protein production with the human adenovirus/293S expression system using fed‐batch strategies I Nadeau, A Garnier, J Cote, B Massie, C Chavarie, A Kamen Biotechnology and bioengineering 51 (6), 613-623, 1996 | 88 | 1996 |
| Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells T Del’Guidice, JP Lepetit-Stoffaes, LJ Bordeleau, J Roberge, V Théberge, ... PloS one 13 (4), e0195558, 2018 | 82 | 2018 |
| High‐titer adenovirus vector production in 293S cell perfusion culture V Cortin, J Thibault, D Jacob, A Garnier Biotechnology progress 20 (3), 858-863, 2004 | 77 | 2004 |
| High‐level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene‐switch B Gaillet, R Gilbert, S Broussau, A Pilotte, F Malenfant, A Mullick, ... Biotechnology and bioengineering 106 (2), 203-215, 2010 | 75 | 2010 |
| Study of adenovirus production in serum‐free 293SF suspension culture by GFP‐expression monitoring J Côté, L Bourget, A Garnier, A Kamen Biotechnology progress 13 (6), 709-714, 1997 | 66 | 1997 |
| Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage φKZ gp144 lytic transglycosylase C Paradis-Bleau, I Cloutier, L Lemieux, F Sanschagrin, J Laroche, ... FEMS microbiology letters 266 (2), 201-209, 2007 | 65 | 2007 |
| A fluorophore-tagged RGD peptide to control endothelial cell adhesion to micropatterned surfaces CA Hoesli, A Garnier, PM Juneau, P Chevallier, C Duchesne, G Laroche Biomaterials 35 (3), 879-890, 2014 | 61 | 2014 |
| Dissolved carbon dioxide accumulation in a large scale and high density production of TGFβ receptor with baculovirus infected Sf-9 cells A Garnier, R Voyer, R Tom, S Perret, B Jardin, A Kamen Cytotechnology 22, 53-63, 1996 | 61 | 1996 |
| Fluorescent labeling in semi-solid medium for selection of mammalian cells secreting high-levels of recombinant proteins AW Caron, C Nicolas, B Gaillet, I Ba, M Pinard, A Garnier, B Massie, ... BMC biotechnology 9, 1-11, 2009 | 59 | 2009 |
| New protocol for lentiviral vector mass production MM Segura, A Garnier, Y Durocher, S Ansorge, A Kamen Lentivirus Gene Engineering Protocols: Second Edition, 39-52, 2010 | 55 | 2010 |
| In vitro reconstruction of the biosynthetic pathway of peptidoglycan cytoplasmic precursor in Pseudomonas aeruginosa A El Zoeiby, F Sanschagrin, PC Havugimana, A Garnier, RC Levesque FEMS microbiology letters 201 (2), 229-235, 2001 | 55 | 2001 |
